Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Astonishing regeneration potential of the pancreas

21.08.2014

Up until puberty, the pancreas is more adaptable and possesses a greater potential for self-healing than had previously been assumed. This is the conclusion reached by a study with mice funded through the National Research Programme "Stem Cells and Regenerative Medicine" (NRP 63).

Approximately 40,000 persons in Switzerland suffer from type-1 diabetes. The illness is caused by the loss of so-called pancreatic beta cells, the cells that produce the hormone insulin, which is essential for regulating the use of sugar in the body.

Since beta cells do not regenerate, scientists have traditionally assumed that the loss of these cells is irreversible; indeed, diabetic patients require insulin injections for life.

Previously unknown mechanism

Four years ago, the research team of Pedro Herrera (University of Geneva) first cast doubt on this assumption when they demonstrated that a few alpha cells in the pancreas of genetically modified diabetic mice changed into beta cells.

Alpha cells normally produce the blood sugar-raising hormone glucagon, but in diabetic mice they started producing insulin instead. Herrera's team has now made a second discovery, which has just been published in the journal "Nature" (*): in prepubescent mice the pancreas is capable of compensating the loss of insulin-producing beta cells. "This is achieved by a mechanism unknown until now," says Herrera.

The process involves the reversion of delta cells (which produce somatostatin, another pancreatic hormone) to a precursor-like cell state, with proliferation and later reconstitution of the populations of beta and delta cells.

In contrast to the conversion of alpha cells, which only concerns a small fraction of the alpha cell population, the new mechanism involving delta cell fate change is a more efficient way of offsetting the loss of beta cells and thus diabetes recovery. Yet while alpha cells can reprogram into insulin production also in old mice, the ability of delta cells to do so is limited and does not extend beyond puberty.

Human pancreas can regenerate too

Although Herrera's group has investigated the versatility of pancreatic cells in mice, several observations in diabetic patients suggest that the human pancreas is capable of transformation too. "The new mechanism shows that the pancreas is much more plastic and – at least during childhood – possesses a much greater potential for self-healing than we had previously assumed," says Herrera.

“There is still a long way to go before diabetes patients might be able to benefit from these findings, but the discovery that delta cells have a high degree of plasticity points to a hitherto unsuspected option for therapeutic intervention.”

(*) S. Chera, D. Baronnier, L. Ghila, V. Cigliola, J. N. Jensen, G. Gu, K. Furuyama, F. Thorel, F. M. Gribble, F. Reimann and P. L. Herrera (2014). Diabetes Recovery By Age-Dependent Conversion of Pancreatic Delta-Cells Into Insulin Producers. Nature online: doi: 10.1038/nature13633
(Journalists can obtain a pdf file from the SNSF by writing to: com@snf.ch)

National Research Programme

"Stem Cells and Regenerative Medicine" (NRP 63)
The aim of NRP 63 is to obtain basic information about the nature, functioning and convertibility of stem cells. NRP 63 also hopes to strengthen stem cell research in Switzerland. It was launched in 2010 and comprises 12 projects. NRP 63 has a budget of CHF 10 million and is scheduled to end next year.


Contact

Prof Pedro L. Herrera
Department of Genetic Medicine and Development
Faculty of Medicine, University of Geneva
Rue Michel-Servet 1
CH-1211 Geneva
Phone: +41 22 379 52 25
E-mail: pedro.herrera@unige.ch

Weitere Informationen:

http://www.snsf.ch/media
http://www.nrp.ch/e

Media - Abteilung Kommunikation | idw - Informationsdienst Wissenschaft

Further reports about: Medicine NRP beta diabetic hormone mechanism pancreas pancreatic producing regenerate

More articles from Health and Medicine:

nachricht Discovery points to a new path toward a universal flu vaccine
03.07.2015 | Rockefeller University

nachricht "CCS Telehealth Ostsachsen", Germany's largest telemedicine project, goes online in Dresden
02.07.2015 | Universitätsklinikum Carl Gustav Carus Dresden

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>